(Q40459002)

20 September 2017

1 reference

title

Beta-lactam antibiotics: is continuous infusion the preferred method of administration? (English)

1 reference

20 September 2017

T G Vondracek

1

1 reference

PubMed ID

7633021

20 September 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

Annals of Pharmacotherapy

20 September 2017

1 reference

20 September 2017

29

1 reference

20 September 2017

4

1 reference

20 September 2017

415-424

1 reference

Continuous infusion of beta-lactam antibiotics

20 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Role of pharmacokinetics in the outcome of infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Comparison of gentamicin dosing regimens using an in-vitro model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

An in vitro pharmacodynamic model to simulate antibiotic behavior of acute otitis media with effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Effect of method of administration on extravascular penetration of four antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Treatment of gram-negative bacillary septicemia with cefoperazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Continuous infusion of ceftazidime in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Cephalosporin antimicrobial agents and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Adverse reactions following intravenous penicillin-G relate to degradation of the drug in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

In vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Subpopulations of variants resistant to imipenem in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Once-a-day beta-lactam antibiotic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900413

10.1177/106002809502900413

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7633021